[Fullver] Intellia Therapeutics Mystery: Why Did the Cure Turn Deadly? Trading the 67% Crash 🕵️♂️
Автор: VALUESTER: The Nasdaq Narrative Podcast
Загружено: 2026-01-14
Просмотров: 5
Описание:
Intellia Therapeutics is a pioneer in in vivo CRISPR gene-editing therapies designed to cure severe genetic diseases. The company is currently facing a crisis after a patient death and subsequent FDA clinical hold on its lead asset, NTLA-2001, due to liver toxicity concerns. This episode investigates the science behind the sudden failure, analyzes the remaining potential of the NTLA-2002 program, and outlines specific technical setups to profit from the stock's extreme volatility.
#IntelliaTherapeutics #NTLA #CRISPR
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: